Predictive Technology Group, Inc. (PRED) Starts Presentation at the 8th Annual LD Micro Invitational
Predictive Technology Group, Inc. (OTC: PRED) aims to revolutionize patient care through predictive data analytics, novel gene-based diagnostics and companion therapeutics through its wholly owned subsidiaries Predictive Therapeutics and Predictive Biotech. These subsidiaries are focuses on endometriosis, scoliosis, degenerative disc disease and regenerative tissue products. The subsidiaries use genetic and other information as cornerstones in the development of new diagnostics that assess a person’s risk of illness and therapeutic products designed to identify, prevent and treat diseases more effectively. For more information, visit the company’s website at www.PredRX.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…